OAM
IMGN

Oppenheimer Asset Management’s Immunogen Inc IMGN Stock Holding History

Oppenheimer Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,190
Closed -$31K – 1474
2020
Q1 		$31K Sell
9,190
-612
-6% -$2.68K ﹤0.01% 1335
2019
Q4 		$50K Sell
9,802
-412
-4% -$1.4K ﹤0.01% 1339
2019
Q3 		$25K Sell
10,214
-766
-7% -$2.03K ﹤0.01% 1439
2019
Q2 		$24K Sell
10,980
-267
-2% -$631 ﹤0.01% 1460
2019
Q1 		$30K Buy
11,247
+38
+0.3% +$165 ﹤0.01% 1418
2018
Q4 		$54K Sell
11,209
-846
-7% -$5.13K ﹤0.01% 1334
2018
Q3 		$114K Sell
12,055
-145
-1% -$1.39K ﹤0.01% 1102
2018
Q2 		$119K Sell
12,200
-712
-6% -$7.51K ﹤0.01% 1093
2018
Q1 		$136K Sell
12,912
-147
-1% -$1.45K ﹤0.01% 1080
2017
Q4 		$100K Hold
13,059
– – ﹤0.01% 1067
2017
Q3 		$100K Buy
13,059
+545
+4% +$3.62K ﹤0.01% 1206
2017
Q2 		$89K Buy
12,514
+76
+0.6% +$348 ﹤0.01% 1220
2017
Q1 		$48K Buy
+12,438
New +$36.3K ﹤0.01% 1361

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oppenheimer Asset Management's IMGN Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Immunogen Inc (IMGN) in Q2 2020, closing a stake of 9,190 shares — an estimated $31K sold.

Oppenheimer Asset Management first reported a position in IMGN in Q1 2017 and held it in 13 quarters. The position peaked at $136K in Q1 2018. 189 funds tracked by Wall St. Rank hold IMGN as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Immunogen Inc position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 9,190 Immunogen Inc shares in Q2 2020, an estimated $31K.
  • Oppenheimer Asset Management first reported a position in Immunogen Inc in Q1 2017 and held it in 13 quarters.
  • Oppenheimer Asset Management's Immunogen Inc position peaked at $136K in Q1 2018.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.